Annual Long Term Debt
$52.66 M
+$12.24 M+30.28%
December 31, 2023
Summary
- As of February 7, 2025, RIGL annual long term debt is $52.66 million, with the most recent change of +$12.24 million (+30.28%) on December 31, 2023.
- During the last 3 years, RIGL annual long term debt has risen by +$22.19 million (+72.84%).
- RIGL annual long term debt is now at all-time high.
Performance
RIGL Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$59.76 M
+$70.00 K+0.12%
September 30, 2024
Summary
- As of February 7, 2025, RIGL quarterly long term debt is $59.76 million, with the most recent change of +$70.00 thousand (+0.12%) on September 30, 2024.
- Over the past year, RIGL quarterly long term debt has dropped by -$363.00 thousand (-0.60%).
- RIGL quarterly long term debt is now -0.87% below its all-time high of $60.29 million, reached on March 31, 2023.
Performance
RIGL Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
RIGL Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.3% | -0.6% |
| 3 y3 years | +72.8% | +189.1% |
| 5 y5 years | +100.0% | +93.0% |
RIGL Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +154.7% | -0.9% | +189.1% |
| 5 y | 5-year | at high | +154.7% | -0.9% | +189.1% |
| alltime | all time | at high | -100.0% | -0.9% | -100.0% |
Rigel Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $59.76 M(+0.1%) |
| Jun 2024 | - | $59.69 M(+32.6%) |
| Mar 2024 | - | $45.01 M(-14.5%) |
| Dec 2023 | $52.66 M(+30.3%) | $52.66 M(-12.4%) |
| Sep 2023 | - | $60.13 M(-0.1%) |
| Jun 2023 | - | $60.20 M(-0.1%) |
| Mar 2023 | - | $60.29 M(+49.1%) |
| Dec 2022 | $40.42 M(+95.5%) | $40.42 M(+2.4%) |
| Sep 2022 | - | $39.47 M(+32.3%) |
| Jun 2022 | - | $29.84 M(-0.0%) |
| Mar 2022 | - | $29.85 M(+44.4%) |
| Dec 2021 | $20.67 M(-32.1%) | $20.67 M(-10.9%) |
| Sep 2021 | - | $23.20 M(-9.8%) |
| Jun 2021 | - | $25.71 M(-8.6%) |
| Mar 2021 | - | $28.14 M(-7.6%) |
| Dec 2020 | $30.47 M(+4.9%) | $30.47 M(-7.0%) |
| Sep 2020 | - | $32.77 M(-6.6%) |
| Jun 2020 | - | $35.06 M(+29.2%) |
| Mar 2020 | - | $27.13 M(-6.6%) |
| Dec 2019 | $29.04 M(>+9900.0%) | $29.04 M(-6.2%) |
| Sep 2019 | - | $30.97 M(+34.1%) |
| Jun 2019 | - | $23.09 M(-7.5%) |
| Mar 2019 | - | $24.95 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(-100.0%) |
| Dec 2010 | $45.00 K(-94.9%) | $45.00 K(-88.5%) |
| Jun 2010 | - | $393.00 K(-37.9%) |
| Mar 2010 | - | $633.00 K(-28.3%) |
| Dec 2009 | $883.00 K(-57.0%) | $883.00 K(-23.5%) |
| Sep 2009 | - | $1.16 M(-19.3%) |
| Jun 2009 | - | $1.43 M(-17.3%) |
| Mar 2009 | - | $1.73 M(-15.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $2.05 M(+161.9%) | $2.05 M(+71.9%) |
| Sep 2008 | - | $1.19 M(+20.7%) |
| Jun 2008 | - | $989.00 K(+36.8%) |
| Mar 2008 | - | $723.00 K(-7.8%) |
| Dec 2007 | $784.00 K(-27.5%) | $784.00 K(-4.2%) |
| Sep 2007 | - | $818.00 K(-21.8%) |
| Jun 2007 | - | $1.05 M(-5.6%) |
| Mar 2007 | - | $1.11 M(+2.4%) |
| Dec 2006 | $1.08 M(-4.4%) | $1.08 M(-16.6%) |
| Sep 2006 | - | $1.30 M(-15.7%) |
| Jun 2006 | - | $1.54 M(-0.7%) |
| Mar 2006 | - | $1.55 M(+36.9%) |
| Dec 2005 | $1.13 M(+44.9%) | $1.13 M(+15.5%) |
| Sep 2005 | - | $980.00 K(-11.2%) |
| Jun 2005 | - | $1.10 M(-13.6%) |
| Mar 2005 | - | $1.28 M(+63.5%) |
| Dec 2004 | $781.00 K(-36.8%) | $781.00 K(+17.4%) |
| Sep 2004 | - | $665.00 K(+7.6%) |
| Jun 2004 | - | $618.00 K(-28.3%) |
| Mar 2004 | - | $862.00 K(-30.3%) |
| Dec 2003 | $1.24 M(-46.6%) | $1.24 M(-20.8%) |
| Sep 2003 | - | $1.56 M(-17.9%) |
| Jun 2003 | - | $1.90 M(+1.9%) |
| Mar 2003 | - | $1.87 M(-19.3%) |
| Dec 2002 | $2.31 M(-45.5%) | $2.31 M(-22.5%) |
| Sep 2002 | - | $2.99 M(-13.8%) |
| Jun 2002 | - | $3.46 M(-7.6%) |
| Mar 2002 | - | $3.75 M(-11.6%) |
| Dec 2001 | $4.24 M(-31.1%) | $4.24 M(-12.1%) |
| Sep 2001 | - | $4.83 M(-13.5%) |
| Jun 2001 | - | $5.58 M(+3.6%) |
| Mar 2001 | - | $5.39 M(-12.6%) |
| Dec 2000 | $6.16 M(+12.5%) | $6.16 M |
| Dec 1999 | $5.48 M | - |
FAQ
- What is Rigel Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual long term debt year-on-year change?
- What is Rigel Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly long term debt year-on-year change?
What is Rigel Pharmaceuticals annual long term debt?
The current annual long term debt of RIGL is $52.66 M
What is the all time high annual long term debt for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual long term debt is $52.66 M
What is Rigel Pharmaceuticals annual long term debt year-on-year change?
Over the past year, RIGL annual long term debt has changed by +$12.24 M (+30.28%)
What is Rigel Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of RIGL is $59.76 M
What is the all time high quarterly long term debt for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly long term debt is $60.29 M
What is Rigel Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, RIGL quarterly long term debt has changed by -$363.00 K (-0.60%)